Imkeldi

{
  "id": "MLC-T-ONC-004191",
  "term": "Imkeldi",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat certain types of leukemia and other blood cancers, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma protuberans, and a certain type of a rare condition called systemic mastocytosis. It is also being studied in the treatment of other conditions and types of cancer. Imkeldi blocks certain proteins made by the BCR::ABL1, PDGFR, or c-KIT oncogene, which may help keep cancer cells from growing and may kill them. Imkeldi is a type of tyrosine kinase inhibitor. Also called Gleevec, imatinib mesylate, and STI571.",
  "synonyms": [
    "Gleevec",
    "imatinib mesylate",
    "STI571"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/imkeldi/"
}